Cytodyn Inc (CYDY)

[daemon57]

So REGN announced this today:
https://investor.regeneron.com/news-releases/news-release-details/phase-3-trial-shows-regen-covtm-casirivimab-imdevimab-antibody/

"PHASE 3 TRIAL SHOWS REGEN-COV™ (CASIRIVIMAB WITH IMDEVIMAB) ANTIBODY COCKTAIL REDUCED HOSPITALIZATION OR DEATH BY 70% IN NON-HOSPITALIZED COVID-19 PATIENTS"

So outpatients who are mild to moderate which a good amount of them that recover on their own, will now have the option of coming back into the hospital to receive 1200mgs of this cocktail VIA IV ??

Meanwhile there's a SUBQ shot thats nearly half the dosage amount, that doesn't take up a bed/chair (for IV) and the FDA mentions:

"FDA recently updated U.S. EUA fact sheets for all authorized monoclonal antibody treatments, indicating that REGEN-COV is the only one to retain potency against key emerging variants" ??

After Emergcy's post and this.. this week is really starting out fairly depressing..

GLTU/A.